Clovis Oncology (CLVS) ROA - Return on Assets
Current and historical Return on Equity (ROE) values for Clovis Oncology (CLVS) over the last 10 years.
|Medical||Medical - Biomedical and Genetics||$2.716B||$0.000B|
|Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. The Company targets its development programs for the treatment of specific subsets of cancer populations. Clovis Oncology Inc. is headquartered in Colorado, USA.|